428 related articles for article (PubMed ID: 21488569)
21. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
Vajda A; Scharrer K; Baló-Banga JM
Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
[TBL] [Abstract][Full Text] [Related]
22. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
Shalin SC; Lyle S; Calonje E; Lazar AJ
Histopathology; 2010 Jan; 56(1):133-47. PubMed ID: 20055911
[TBL] [Abstract][Full Text] [Related]
23. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
John AM; Schwartz RA
J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
[TBL] [Abstract][Full Text] [Related]
24. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
Neelakantan IV; Di Palma S; Smith CE; McCoombe A
Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
[TBL] [Abstract][Full Text] [Related]
25. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
[TBL] [Abstract][Full Text] [Related]
26. [Muir-Torre syndrome. Apropos of a case associated with a familial form of cancer].
Prunet D; Lehur PA; Guiberteau-Canfrère V; Thébaud Y; Litoux P; Le Borgne J
Ann Chir; 1992; 46(10):944-6. PubMed ID: 1300910
[TBL] [Abstract][Full Text] [Related]
27. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
[TBL] [Abstract][Full Text] [Related]
28. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.
Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
[TBL] [Abstract][Full Text] [Related]
30. Sebaceous neoplasms in Muir-Torre syndrome.
Misago N; Narisawa Y
Am J Dermatopathol; 2000 Apr; 22(2):155-61. PubMed ID: 10770437
[TBL] [Abstract][Full Text] [Related]
31. [Muir-Torre syndrome].
Tiszlavicz L; Hódi Z; Tihanyi Z
Orv Hetil; 1999 Jan; 140(5):251-4. PubMed ID: 10064979
[TBL] [Abstract][Full Text] [Related]
32. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
[TBL] [Abstract][Full Text] [Related]
33. Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?
Arsenovic N; Ramaiya A
Dermatol Online J; 2009 Nov; 15(11):11. PubMed ID: 19951647
[TBL] [Abstract][Full Text] [Related]
34. [Isolated conjunctival sebaceous adenoma associated with acute endophtalmitis].
Tresserra F; Elizalde J; Ferre B; Gómez-Benlloch A; Martínez-Lanao MÁ; López R
Rev Esp Patol; 2022; 55(1):68-72. PubMed ID: 34980445
[TBL] [Abstract][Full Text] [Related]
35. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
[TBL] [Abstract][Full Text] [Related]
36. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations.
Ponti G; Ponz de Leon M; Maffei S; Pedroni M; Losi L; Di Gregorio C; Gismondi V; Scarselli A; Benatti P; Roncari B; Seidenari S; Pellacani G; Varotti C; Prete E; Varesco L; Roncucci L
Clin Genet; 2005 Nov; 68(5):442-7. PubMed ID: 16207212
[TBL] [Abstract][Full Text] [Related]
37. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
38. Muir-Torre syndrome.
Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
[TBL] [Abstract][Full Text] [Related]
39. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
Fernandez-Flores A
Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
[TBL] [Abstract][Full Text] [Related]
40. Muir-Torre syndrome: a case report and review of the literature.
Okan G; Vural P; Ince Ü; Yazar A; Uras C; Saruç M
Turk J Gastroenterol; 2012 Aug; 23(4):394-8. PubMed ID: 22965514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
